Level 7, Macquarie House, 167 Macquarie Street, Sydney, NSW, 2000, Australia
Lab 186, ATC Building Callaghan Campus, University of Newcastle, University Drive, Callaghan NSW 2308 Australia
Y-Block, Queensland Centre for Advanced Technologies (QCAT), 1 Technology Court, Pullenvale, QLD 4069, Australia
B78 Prescott Laboratories, The Braggs Building, The University of Adelaide, Adelaide, SA, 5005
AdvanCell operates a comprehensive partnership program for taking novel radioligand therapies from the lab through to Phase 1 and beyond.
AdvanCell provides its cGMP isotope to partners removing reliance on external supply chains.
AdvanCell’s in-house manufacturing team and infrastructure ensures CMC development to meet FDA requirements.
AdvanCell has deep experience in running clinical trials for radioligand therapies.
Australia’s world-leading Nuclear Medicine expertise and infrastructure offers a smooth and competitive path for clinical development.